Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study
Dan Frampton, Tommy Rampling, Aidan Cross, et al.
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 9, pp. 1246-1256
Open Access | Times Cited: 443

Showing 1-25 of 443 citing articles:

Mechanisms of SARS-CoV-2 entry into cells
Cody B. Jackson, Michael Farzan, Bing Chen, et al.
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 1, pp. 3-20
Open Access | Times Cited: 2410
The N501Y spike substitution enhances SARS-CoV-2 infection and transmission
Yang Liu, Jianying Liu, Kenneth S. Plante, et al.
Nature (2021) Vol. 602, Iss. 7896, pp. 294-299
Open Access | Times Cited: 483
Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta)
Sean Wei Xiang Ong, Calvin J. Chiew, Li Wei Ang, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e1128-e1136
Open Access | Times Cited: 389
After the pandemic: perspectives on the future trajectory of COVID-19
Amalio Telenti, Ann M. Arvin, Lawrence Corey, et al.
Nature (2021) Vol. 596, Iss. 7873, pp. 495-504
Open Access | Times Cited: 388
Tackling COVID-19 with neutralizing monoclonal antibodies
Davide Corti, Lisa A. Purcell, Gyorgy Snell, et al.
Cell (2021) Vol. 184, Iss. 12, pp. 3086-3108
Open Access | Times Cited: 369
Novel SARS-CoV-2 variants: the pandemics within the pandemic
Erik Boehm, Ilona Kronig, Richard A. Neher, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 8, pp. 1109-1117
Open Access | Times Cited: 358
The emergence, genomic diversity and global spread of SARS-CoV-2
Juan Li, Shengjie Lai, George F. Gao, et al.
Nature (2021) Vol. 600, Iss. 7889, pp. 408-418
Open Access | Times Cited: 344
Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates
Kizzmekia S. Corbett, Martha Nason, Britta Flach, et al.
Science (2021) Vol. 373, Iss. 6561
Open Access | Times Cited: 298
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination
Markus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger, et al.
Cell Reports (2021) Vol. 36, Iss. 3, pp. 109415-109415
Open Access | Times Cited: 232
Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study
Katia Bruxvoort, Lina S. Sy, Lei Qian, et al.
BMJ (2021), pp. e068848-e068848
Open Access | Times Cited: 221
The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology
Bas B. Oude Munnink, Nathalie Worp, David F. Nieuwenhuijse, et al.
Nature Medicine (2021) Vol. 27, Iss. 9, pp. 1518-1524
Open Access | Times Cited: 220
Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China
Yaping Wang, Ruchong Chen, Fengyu Hu, et al.
EClinicalMedicine (2021) Vol. 40, pp. 101129-101129
Open Access | Times Cited: 216
The Disease Severity and Clinical Outcomes of the SARS-CoV-2 Variants of Concern
Lixin Lin, Ying Liu, Xiujuan Tang, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 213
Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergence
Moritz U. G. Kraemer, Verity Hill, Christopher Ruis, et al.
Science (2021) Vol. 373, Iss. 6557, pp. 889-895
Open Access | Times Cited: 202
The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges
Jonaid Ahmad Malik, Sakeel Ahmed, Mir Aroosa, et al.
Journal of Infection and Public Health (2022) Vol. 15, Iss. 2, pp. 228-240
Open Access | Times Cited: 173
SARS‐CoV‐2 Alpha, Beta, and Delta variants display enhanced Spike‐mediated syncytia formation
Maaran Michael Rajah, Mathieu Hubert, Elodie Bishop, et al.
The EMBO Journal (2021) Vol. 40, Iss. 24
Open Access | Times Cited: 171
Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study
Peter Bager, Jan Wohlfahrt, Jannik Fonager, et al.
The Lancet Infectious Diseases (2021) Vol. 21, Iss. 11, pp. 1507-1517
Open Access | Times Cited: 150
Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinct
Anna Z. Mykytyn, Melanie Rissmann, Adinda Kok, et al.
Science Immunology (2022) Vol. 7, Iss. 75
Open Access | Times Cited: 142
Infection With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta Variant Is Associated With Higher Recovery of Infectious Virus Compared to the Alpha Variant in Both Unvaccinated and Vaccinated Individuals
Chun Huai Luo, C. Paul Morris, Jaiprasath Sachithanandham, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e715-e725
Open Access | Times Cited: 140
Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Infectious Virus Loads Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals
Chun Huai Luo, C. Paul Morris, Jaiprasath Sachithanandham, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 134
Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy
Sindhu Ramesh, Manoj Govindarajulu, Rachel S. Parise, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1195-1195
Open Access | Times Cited: 131
mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions
Paulina Kapłonek, Deniz Cizmeci, Stephanie Fischinger, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 645
Open Access | Times Cited: 122
Emerging SARS-CoV-2 Variants of Concern (VOCs): An Impending Global Crisis
Angel Yun-Kuan Thye, Jodi Woan‐Fei Law, Priyia Pusparajah, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1303-1303
Open Access | Times Cited: 120
A look into the future of the COVID-19 pandemic in Europe: an expert consultation
Emil N. Iftekhar, Viola Priesemann, Rudi Balling, et al.
The Lancet Regional Health - Europe (2021) Vol. 8, pp. 100185-100185
Open Access | Times Cited: 117
The Spike of Concern—The Novel Variants of SARS-CoV-2
Anna Winger, Thomas Caspari
Viruses (2021) Vol. 13, Iss. 6, pp. 1002-1002
Open Access | Times Cited: 110
Page 1 - Next Page

Scroll to top